{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T01:45:09Z","timestamp":1795139109806,"version":"4.10.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1038\/s41409-025-02715-x","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T17:28:01Z","timestamp":1759166881000},"page":"1628-1634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["BEAM\/ATG or cyclophosphamide\/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party"],"prefix":"10.1038","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6117-5328","authenticated-orcid":false,"given":"Raffaella","family":"Greco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Saccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ponzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3226-2024","authenticated-orcid":false,"given":"Manuela","family":"Badoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Helbig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Smilowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1869-7067","authenticated-orcid":false,"given":"Alice","family":"Mariottini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7045-1806","authenticated-orcid":false,"given":"Joachim","family":"Burman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6863-6297","authenticated-orcid":false,"given":"Majid","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3822-1218","authenticated-orcid":false,"given":"Paolo A.","family":"Muraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Withers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Massey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Varaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Inglese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6934-4619","authenticated-orcid":false,"given":"Jaime","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Gil-Perotin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil","family":"Sharrack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7242-170X","authenticated-orcid":false,"given":"Elisa","family":"Roldan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Nozzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Signori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Sormani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1193-0097","authenticated-orcid":false,"given":"Tobias","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6819-3476","authenticated-orcid":false,"given":"John A.","family":"Snowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"2715_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/sj.bmt.1700944","volume":"20","author":"A Fassas","year":"1997","unstructured":"Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis V, et al. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study. Bone Marrow Transplant. 1997;20:631\u20138. https:\/\/doi.org\/10.1038\/sj.bmt.1700944.","journal-title":"Bone Marrow Transplant"},{"key":"2715_CR2","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/sj.bmt.1701129","volume":"21","author":"RK Burt","year":"1998","unstructured":"Burt RK, Traynor AE, Cohen B, Karlin KH, Davis FA, Stefoski D, et al. T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients. Bone Marrow Transplant. 1998;21:537\u201341. https:\/\/doi.org\/10.1038\/sj.bmt.1701129.","journal-title":"Bone Marrow Transplant"},{"key":"2715_CR3","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/s41409-022-01702-w","volume":"57","author":"T Alexander","year":"2022","unstructured":"Alexander T, Greco R. Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2022;57:1055\u201362. https:\/\/doi.org\/10.1038\/s41409-022-01702-w.","journal-title":"Bone Marrow Transplant"},{"key":"2715_CR4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011461","author":"G Boffa","year":"2021","unstructured":"Boffa G, Massacesi L, Inglese M, Mariottini A, Capobianco M, Lucia M, et al. Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis. Neurology. 2021. https:\/\/doi.org\/10.1212\/WNL.0000000000011461.","journal-title":"Neurology"},{"key":"2715_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.2018.18743","volume":"321","author":"RK Burt","year":"2019","unstructured":"Burt RK, Balabanov R, Burman J, Sharrack B, Snowden JA, Oliveira MC, et al. Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial. JAMA. 2019;321:165\u201374. https:\/\/doi.org\/10.1001\/jama.2018.18743.","journal-title":"JAMA"},{"key":"2715_CR6","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1177\/1352458520985238","volume":"27","author":"J Das","year":"2021","unstructured":"Das J, Snowden JA, Burman J, Freedman MS, Atkins H, Bowman M, et al. Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with \u2018aggressive\u2019 multiple sclerosis. Mult Scler. 2021;27:1198\u2013204. https:\/\/doi.org\/10.1177\/1352458520985238.","journal-title":"Mult Scler"},{"key":"2715_CR7","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1212\/WNL.0000000000001329","volume":"84","author":"GL Mancardi","year":"2015","unstructured":"Mancardi GL, Sormani MP, Gualandi F, Saiz A, Carreras E, Merelli E, et al. Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial. Neurology. 2015;84:981\u20138. https:\/\/doi.org\/10.1212\/WNL.0000000000001329.","journal-title":"Neurology"},{"key":"2715_CR8","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/bmt.2011.185","volume":"47","author":"JA Snowden","year":"2012","unstructured":"Snowden JA, Saccardi R, Allez M, Ardizzone S, Arnold R, Cervera R, et al. Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2012;47:770\u201390. https:\/\/doi.org\/10.1038\/bmt.2011.185.","journal-title":"Bone Marrow Transplant"},{"key":"2715_CR9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41409-019-0684-0","volume":"55","author":"B Sharrack","year":"2020","unstructured":"Sharrack B, Saccardi R, Alexander T, Badoglio M, Burman J, Farge D, et al. Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE). Bone Marrow Transplant. 2020;55:283\u2013306. https:\/\/doi.org\/10.1038\/s41409-019-0684-0.","journal-title":"Bone Marrow Transplant"},{"key":"2715_CR10","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41409-022-01691-w","volume":"57","author":"JA Snowden","year":"2022","unstructured":"Snowden JA, Sanchez-Ortega I, Corbacioglu S, Basak GW, Chabannon C, de la Camara R, et al. Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022. Bone Marrow Transplant. 2022;57:1217\u201339. https:\/\/doi.org\/10.1038\/s41409-022-01691-w.","journal-title":"Bone Marrow Transplant"},{"key":"2715_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-024-01050-x","author":"PA Muraro","year":"2025","unstructured":"Muraro PA, Mariottini A, Greco R, Burman J, Iacobaeus E, Inglese M, et al. Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMT. Nat Rev Neurol. 2025. https:\/\/doi.org\/10.1038\/s41582-024-01050-x.","journal-title":"Nat Rev Neurol"},{"key":"2715_CR12","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1177\/1352458512438454","volume":"18","author":"R Saccardi","year":"2012","unstructured":"Saccardi R, Freedman MS, Sormani MP, Atkins H, Farge D, Griffith LM, et al. A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. Mult Scler. 2012;18:825\u201334. https:\/\/doi.org\/10.1177\/1352458512438454.","journal-title":"Mult Scler"},{"key":"2715_CR13","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1182\/bloodadvances.2017010041","volume":"1","author":"JA Snowden","year":"2017","unstructured":"Snowden JA, Badoglio M, Labopin M, Giebel S, McGrath E, Marjanovic Z, et al. Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases. Blood Adv. 2017;1:2742\u201355. https:\/\/doi.org\/10.1182\/bloodadvances.2017010041.","journal-title":"Blood Adv"},{"key":"2715_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1001\/jamaneurol.2016.5867","volume":"74","author":"PA Muraro","year":"2017","unstructured":"Muraro PA, Pasquini M, Atkins HL, Bowen JD, Farge D, Fassas A, et al. Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis. JAMA Neurol. 2017;74:459\u201369. https:\/\/doi.org\/10.1001\/jamaneurol.2016.5867.","journal-title":"JAMA Neurol"},{"key":"2715_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/B978-0-323-90242-7.00008-0","volume":"202","author":"R Greco","year":"2024","unstructured":"Greco R, Badoglio M, Labopin M, Kaur M, Pasquini MC. The EBMT-ADWP and the CIBMTR. Handb Clin Neurol. 2024;202:295\u2013305. https:\/\/doi.org\/10.1016\/B978-0-323-90242-7.00008-0.","journal-title":"Handb Clin Neurol"},{"key":"2715_CR16","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.1002\/art.22256","volume":"54","author":"RK Burt","year":"2006","unstructured":"Burt RK, Marmont A, Oyama Y, Slavin S, Arnold R, Hiepe F, et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum. 2006;54:3750\u201360. https:\/\/doi.org\/10.1002\/art.22256.","journal-title":"Arthritis Rheum"},{"key":"2715_CR17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S1474-4422(09)70017-1","volume":"8","author":"RK Burt","year":"2009","unstructured":"Burt RK, Loh Y, Cohen B, Stefoski D, Balabanov R, Katsamakis G, et al. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I\/II study. Lancet Neurol. 2009;8:244\u201353. https:\/\/doi.org\/10.1016\/S1474-4422(09)70017-1.","journal-title":"Lancet Neurol"},{"key":"2715_CR18","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1038\/s41409-024-02397-x","volume":"59","author":"T Silfverberg","year":"2024","unstructured":"Silfverberg T, Zjukovskaja C, Noui Y, Carlson K, Auto MSSI, Burman J. BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis. Bone Marrow Transplant. 2024;59:1601\u201310. https:\/\/doi.org\/10.1038\/s41409-024-02397-x.","journal-title":"Bone Marrow Transplant"},{"key":"2715_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17:162\u201373. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2.","journal-title":"Lancet Neurol"},{"key":"2715_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/1352458516645670","volume":"23","author":"MP Sormani","year":"2017","unstructured":"Sormani MP, Muraro PA, Saccardi R, Mancardi G. NEDA status in highly active MS can be more easily obtained with autologous hematopoietic stem cell transplantation than other drugs. Mult Scler. 2017;23:201\u20134. https:\/\/doi.org\/10.1177\/1352458516645670.","journal-title":"Mult Scler"},{"key":"2715_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.msard.2012.12.001","volume":"2","author":"B Banwell","year":"2013","unstructured":"Banwell B, Giovannoni G, Hawkes C, Lublin F. Editors\u2019 welcome and a working definition for a multiple sclerosis cure. Mult Scler Relat Disord. 2013;2:65\u201367. https:\/\/doi.org\/10.1016\/j.msard.2012.12.001.","journal-title":"Mult Scler Relat Disord"},{"key":"2715_CR22","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/wnl.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444\u201352. https:\/\/doi.org\/10.1212\/wnl.33.11.1444.","journal-title":"Neurology"},{"key":"2715_CR23","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1038\/s41409-024-02383-3","volume":"59","author":"A Ismail","year":"2024","unstructured":"Ismail A, Nitti R, Sharrack B, Badoglio M, Ambron P, Labopin M, et al. ATG and other serotherapy in conditioning regimens for autologous HSCT in autoimmune diseases: a survey on behalf of the EBMT Autoimmune Diseases Working Party (ADWP). Bone Marrow Transplant. 2024;59:1614\u20137. https:\/\/doi.org\/10.1038\/s41409-024-02383-3.","journal-title":"Bone Marrow Transplant"},{"key":"2715_CR24","doi-asserted-by":"crossref","unstructured":"Burt RK, Farge D, Ruiz MA, Saccardi R, Snowden JA Hematopoietic Stem Cell Transplantation and Cellular Therapies for Autoimmune Diseases. 2021; eBook: 978-1-315-15136-6: https:\/\/www.routledge.com\/Hematopoietic-Stem-Cell-Transplantation-and-Cellular-Therapies-for-Autoimmune\/Burt-Farge-Ruiz-Saccardi-Snowden\/p\/book\/978113855855.","DOI":"10.1201\/9781315151366"},{"key":"2715_CR25","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/S0140-6736(16)30169-6","volume":"388","author":"HL Atkins","year":"2016","unstructured":"Atkins HL, Bowman M, Allan D, Anstee G, Arnold DL, Bar-Or A, et al. Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial. Lancet. 2016;388:576\u201385. https:\/\/doi.org\/10.1016\/S0140-6736(16)30169-6.","journal-title":"Lancet"},{"key":"2715_CR26","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1007\/s00415-021-10820-2","volume":"269","author":"RK Burt","year":"2022","unstructured":"Burt RK, Han X, Quigley K, Helenowski IB, Balabanov R. Real-world application of autologous hematopoietic stem cell transplantation in 507 patients with multiple sclerosis. J Neurol. 2022;269:2513\u201326. https:\/\/doi.org\/10.1007\/s00415-021-10820-2.","journal-title":"J Neurol"},{"key":"2715_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41409-024-02461-6","volume":"60","author":"T Alexander","year":"2025","unstructured":"Alexander T, Badoglio M, Labopin M, Daikeler T, Farge D, Kazmi M, et al. Monitoring and management of CMV and EBV after autologous haematopoietic stem cell transplantation for autoimmune diseases: a survey of the EBMT Autoimmune Diseases Working party (ADWP). Bone Marrow Transplant. 2025;60:110\u20133. https:\/\/doi.org\/10.1038\/s41409-024-02461-6.","journal-title":"Bone Marrow Transplant"},{"key":"2715_CR28","doi-asserted-by":"crossref","unstructured":"Tramacere I, Virgili G, Perduca V, Lucenteforte E, Benedetti MD, Capobussi M, et al. Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis. Cochrane Database Syst Rev. 2023;11:CD012186.","DOI":"10.1002\/14651858.CD012186.pub2"},{"key":"2715_CR29","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/bmt.2014.248","volume":"50","author":"E Snarski","year":"2015","unstructured":"Snarski E, Snowden JA, Oliveira MC, Simoes B, Badoglio M, Carlson K, et al. Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP). Bone Marrow Transplant. 2015;50:216\u201320. https:\/\/doi.org\/10.1038\/bmt.2014.248.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02715-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02715-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02715-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T08:09:11Z","timestamp":1764662951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02715-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2715"],"URL":"https:\/\/doi.org\/10.1038\/s41409-025-02715-x","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AM discloses speaker honoraria for educational events from Biogen, Janssen, Merck, Novartis, Sandoz, Sanofi, Viatris. ER declares speaker honoraria from Janssen. JAS discloses honoraria for advisory boards from Vertex, Jazz, BMS and Medac. PAM declares consulting for Teva, Glenmark and Cellerys. RG declares speaker honoraria for educational events from Biotest, Pfizer, Medac, Qiagen, Kyverna MSD and Magenta and advisory board from Pfizer, BMS. TA declares study support from Janssen Cilag. The remaining authors have nothing to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study and registry data analysis were approved, led and supported by the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT). Patients provided informed written consent for the inclusion of their non-identifiable data into the EBMT Registry. The study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}